The use of antibacterial medicine in Poland has shown fluctuations over the past decade. From 2014 to 2023, usage varied significantly, peaking in 2017 and seeing a notable decrease in 2020. In 2023, the use stood at 23.9 Units (Defined Daily Dosage) Per Thousand Persons Per Day, representing a 4.82% increase from 2022. Over the last five years, the compound annual growth rate (CAGR) was relatively flat at -0.41%. Future projections suggest a stable trend with a slight annual decline of -0.08% CAGR expected from 2024 to 2028, indicating minimal changes in usage patterns.
In future trends, keep an eye on factors such as the development of antibiotic resistance, advancements in alternative treatments, and any changes in healthcare policies or public health campaigns aimed at reducing antibacterial usage. Monitoring these elements will be crucial in anticipating potential shifts in antibacterial medicine consumption in Poland.
